Clinical trial
Triple-Blind Clinical Trial With Placebo Control to Evaluate the Efficacy of a Heparin of Low Molecular Weight (Bemiparin) for Treating Slow-Responding Ulcers in Diabetic Foot in Primary Care
NCT00399425 is registered in ClinicalTrials.gov with Spanish National Health System as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Triple-Blind Clinical Trial With Placebo Control to Evaluate the Efficacy of a Heparin of Low Molecular Weight (Bemiparin) for Treating Slow-Responding Ulcers in Diabetic Foot in Primary Care
- Lead sponsor
- Spanish National Health System
- Phase
- Phase 2/3
- Overall status
- Terminated
- Start date
- June 30, 2001
- Completion date
- April 30, 2004
- Enrollment
- 84
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
diabetic angiopathies, foot ulcer, diabetic